11-Dec-14 Medtronic will turn over more than USD900 million in China this year, up from only USD50 million ten years ago. Its China strategy is multi-faceted, involving imports, local R&D, patient education and M&A. Despite this success, the advantage Medtronic - along with other foreign device makers - has carved out, is increasingly under pressure from local players, whose ability to innovate and drive costs down via frugal engineering is creating a new standard of excellence. [image: China Business Review]

10-Dec-14 India’s fast-growing medical devices market is dogged by tax and regulatory anomalies and malpractices, making it difficult for local manufacturers. Good news: These problems will be addressed soon by the Drugs & Cosmetics (Amendment) Bill 2014, which is expected to be passed in the current parliament session. [image: PV Sivakumar_The Hindu Business Line]

10-Dec-14 Mergers and acquisitions in China’s healthcare sector rose to a record USD11.3 billion in the first 11 months of 2014, up 13% from a year earlier. A combination of ageing population and increasing affluence is driving the deal-making, coinciding with sweeping reforms by Chinese government. [image: Feucht Blog]

For more about China's healthcare sector, download our free 20-page whitepaper: China healthcare market opportunities

09-Dec-14 Increasing numbers of hospitals in Vietnam are being equipped with modern technology and German companies are at the forefront: Siemens has been providing imaging and laboratory diagnostics since 1993, B. Braun is raising its investment in Vietnam to USD270 million, and other German firms doing well in Vietnam include Boehringer Ingelheim, Draeger, Rudolf Lietz, Fresenius Kabi, Bayer Schering and Merck. [image: Vietnam Investment Review]

04-Dec-14 GE Healthcare Life Sciences is planning to open a Technology Laboratory in Turkey which will feature the company’s latest tools for drug discovery, protein science and bioprocessing research. Turkey plans to transform its domestic manufacturing of devices and pharmaceuticals, with plans for 60% of demand to be met locally. [image: GE Healthcare Life Sciences]